Winthrop Advisory Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$344K Sell
14,212
-677
-5% -$16.4K 0.03% 124
2025
Q1
$377K Sell
14,889
-622
-4% -$15.8K 0.05% 103
2024
Q4
$412K Sell
15,511
-323
-2% -$8.57K 0.05% 103
2024
Q3
$458K Buy
15,834
+397
+3% +$11.5K 0.06% 92
2024
Q2
$432K Sell
15,437
-34
-0.2% -$951 0.06% 92
2024
Q1
$429K Sell
15,471
-413
-3% -$11.5K 0.06% 92
2023
Q4
$457K Sell
15,884
-925
-6% -$26.6K 0.07% 84
2023
Q3
$558K Sell
16,809
-856
-5% -$28.4K 0.09% 64
2023
Q2
$648K Sell
17,665
-105
-0.6% -$3.85K 0.1% 65
2023
Q1
$725K Sell
17,770
-816
-4% -$33.3K 0.13% 58
2022
Q4
$952K Buy
18,586
+1,386
+8% +$71K 0.18% 50
2022
Q3
$753K Buy
17,200
+1,653
+11% +$72.4K 0.16% 49
2022
Q2
$815K Sell
15,547
-17
-0.1% -$891 0.19% 47
2022
Q1
$806K Buy
15,564
+452
+3% +$23.4K 0.17% 49
2021
Q4
$892K Buy
15,112
+23
+0.2% +$1.36K 0.18% 47
2021
Q3
$649K Buy
15,089
+759
+5% +$32.6K 0.14% 52
2021
Q2
$561K Sell
14,330
-706
-5% -$27.6K 0.13% 55
2021
Q1
$545K Sell
15,036
-1,787
-11% -$64.8K 0.13% 57
2020
Q4
$619K Buy
16,823
+1,495
+10% +$55K 0.16% 50
2020
Q3
$536K Buy
15,328
+2,346
+18% +$82K 0.16% 51
2020
Q2
$416K Buy
12,982
+23
+0.2% +$737 0.15% 50
2020
Q1
$401K Sell
12,959
-82
-0.6% -$2.54K 0.16% 47
2019
Q4
$485K Buy
13,041
+226
+2% +$8.41K 0.17% 54
2019
Q3
$437K Buy
12,815
+12
+0.1% +$409 0.17% 52
2019
Q2
$526K Sell
12,803
-116
-0.9% -$4.77K 0.22% 45
2019
Q1
$523K Buy
12,919
+31
+0.2% +$1.26K 0.23% 46
2018
Q4
$534K Buy
12,888
+939
+8% +$38.9K 0.27% 43
2018
Q3
$500K Buy
11,949
+145
+1% +$6.07K 0.28% 42
2018
Q2
$406K Buy
11,804
+4
+0% +$138 0.27% 45
2018
Q1
$414K Sell
11,800
-552
-4% -$19.4K 0.29% 46
2017
Q4
$427K Buy
+12,352
New +$427K 0.3% 46